Valuation: DexCom, Inc.

Market Cap 32.21B 584B 28.63B 26.69B 24.33B 45.89B 3,102B 46.33B 323B 125B 1,582B 121B 118B 5,084B P/E 2026 *
34.3x
P/E 2027 * 28.9x
Enterprise Value 31.45B 571B 27.95B 26.06B 23.75B 44.81B 3,029B 45.23B 316B 122B 1,544B 118B 116B 4,964B EV / Sales 2026 *
6.01x
EV / Sales 2027 * 5.37x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+0.48%
1 month+0.48%
3 months+23.10%
6 months+27.00%
Current year+26.65%
1 month 1,536.29
Extreme 1536.29
1,536.29
Current year 1,064.65
Extreme 1064.65
1,556.82
1 year 1,062.55
Extreme 1062.55
1,556.82
3 years 1,062.55
Extreme 1062.55
2,260
5 years 1,062.55
Extreme 1062.55
3,366.38
10 years 212.78
Extreme 212.775
3,366.38
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--% - - 32.21B
+0.84%-3.74%-26.69%+1.85% 169B
-0.07%-2.55%-9.53%+11.07% 110B
+0.90%+1.13%-24.83%+0.58% 106B
-1.24%-0.76%-49.04%-12.75% 73.87B
-0.24%+0.69%+0.16%+72.58% 58.98B
-0.86%+2.96%+13.57%+59.50% 51.28B
-0.71%-3.82%-7.72%-31.41% 48.16B
+0.12%-0.17%-18.21%+20.29% 40.84B
-1.01%-1.45%+28.48%-9.72% 32.21B
Average -0.18%-0.86%-10.42%+12.44% 76.69B
Weighted average by Cap. +0.05%-1.30%-16.36%+10.13%

Financials

2026 *2027 *
Net sales 5.23B 94.9B 4.65B 4.33B 3.95B 7.45B 504B 7.52B 52.52B 20.36B 257B 19.63B 19.21B 825B 5.8B 105B 5.16B 4.81B 4.38B 8.26B 559B 8.34B 58.24B 22.57B 285B 21.77B 21.3B 915B
Net income 974M 17.68B 866M 807M 736M 1.39B 93.83B 1.4B 9.78B 3.79B 47.85B 3.66B 3.58B 154B 1.15B 20.85B 1.02B 952M 868M 1.64B 111B 1.65B 11.54B 4.47B 56.42B 4.31B 4.22B 181B
Net Debt -761M -13.81B -677M -631M -575M -1.08B -73.3B -1.09B -7.64B -2.96B -37.38B -2.86B -2.8B -120B -1.06B -19.26B -943M -879M -802M -1.51B -102B -1.53B -10.66B -4.13B -52.13B -3.98B -3.9B -168B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
85.36USD
Average target price
95.08USD
Spread / Average Target
+11.39%

Quarterly revenue - Rate of surprise